Jasmine Jhihan B. Clark

Array ( [id] => 3695001 [patent_doc_number] => 05595884 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-21 [patent_title] => 'Papillomavirus E2 transactivation repressor proteins and DNA' [patent_app_type] => 1 [patent_app_number] => 8/094128 [patent_app_country] => US [patent_app_date] => 1993-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 20606 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/595/05595884.pdf [firstpage_image] =>[orig_patent_app_number] => 094128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3555364 [patent_doc_number] => 05543394 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-06 [patent_title] => 'Bone morphogenetic protein 5(BMP-5) compositions' [patent_app_type] => 1 [patent_app_number] => 8/116425 [patent_app_country] => US [patent_app_date] => 1993-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12608 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/543/05543394.pdf [firstpage_image] =>[orig_patent_app_number] => 116425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3541478 [patent_doc_number] => 05480966 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-02 [patent_title] => 'Peptides derived from the envelope glycoprotein of HIV viruses, their applications to the detection of infection caused by these viruses and to the vaccination against AIDS' [patent_app_type] => 1 [patent_app_number] => 8/116252 [patent_app_country] => US [patent_app_date] => 1993-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4803 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/480/05480966.pdf [firstpage_image] =>[orig_patent_app_number] => 116252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3410698 [patent_doc_number] => 05411886 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-02 [patent_title] => 'Xylose isomerase gene of Thermus aquaticus' [patent_app_type] => 1 [patent_app_number] => 8/112630 [patent_app_country] => US [patent_app_date] => 1993-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5028 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/411/05411886.pdf [firstpage_image] =>[orig_patent_app_number] => 112630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3106300 [patent_doc_number] => 05407810 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-18 [patent_title] => 'Aqueous multiple-phase isolation of polypeptide' [patent_app_type] => 1 [patent_app_number] => 8/110663 [patent_app_country] => US [patent_app_date] => 1993-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18635 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/407/05407810.pdf [firstpage_image] =>[orig_patent_app_number] => 110663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3416957 [patent_doc_number] => 05434067 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-18 [patent_title] => 'Process for the production and renaturation of recombinant, biologically active, eukaryotic alkaline phosphatase' [patent_app_type] => 1 [patent_app_number] => 8/100124 [patent_app_country] => US [patent_app_date] => 1993-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6086 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/434/05434067.pdf [firstpage_image] =>[orig_patent_app_number] => 100124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3416434 [patent_doc_number] => 05453374 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-26 [patent_title] => 'Trigonopsis transformant producing D-amino acid oxidase' [patent_app_type] => 1 [patent_app_number] => 8/096741 [patent_app_country] => US [patent_app_date] => 1993-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6798 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/453/05453374.pdf [firstpage_image] =>[orig_patent_app_number] => 096741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3538795 [patent_doc_number] => 05494895 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-27 [patent_title] => 'Scorpion peptide margatoxin with immunosuppressant activity' [patent_app_type] => 1 [patent_app_number] => 8/096942 [patent_app_country] => US [patent_app_date] => 1993-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8653 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/494/05494895.pdf [firstpage_image] =>[orig_patent_app_number] => 096942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2999453 [patent_doc_number] => 05359039 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-25 [patent_title] => 'Isolated poxvirus A53R-equivalent tumor necrosis factor antagonists' [patent_app_type] => 1 [patent_app_number] => 8/089458 [patent_app_country] => US [patent_app_date] => 1993-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9699 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/359/05359039.pdf [firstpage_image] =>[orig_patent_app_number] => 089458 [rel_patent_id] =>[rel_patent_doc_number] =>)